Profile data is unavailable for this security.
About the company
Jiangsu GDK Biotechnology Co Ltd is a China-based company principally engaged in the research, development, production, and sales of human vaccines. The Company’s products mainly include human vaccines for the prevention of infectious diseases such as influenza, rabies, chickenpox, shingles, and pneumonia. The Company mainly operates its businesses in the domestic market.
- Revenue in CNY (TTM)116.56m
- Net income in CNY-126.51m
- Incorporated2008
- Employees452.00
- LocationJiangsu GDK Biotechnology Co LtdNo. 12 Yujin RoadTAIZHOU 225300ChinaCHN
- Phone+86 52 386205860
- Fax+86 52 386200152
- Websitehttp://www.gdkbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hunan Nucien Pharmaceutical Co Ltd | 119.87m | -353.70m | 2.33bn | 360.00 | -- | 2.69 | -- | 19.44 | -1.28 | -1.28 | 0.4362 | 3.16 | 0.0998 | 1.41 | 0.4888 | -- | -32.50 | -5.94 | -36.98 | -8.19 | 32.41 | 83.51 | -325.67 | -15.02 | 2.29 | -139.49 | 0.1562 | -- | -64.64 | -23.64 | -9,613.65 | -- | 35.48 | -- |
| Shaanxi Kanghui Pharmaceutical Co Ltd | 513.23m | -183.84m | 2.37bn | 906.00 | -- | 3.27 | -- | 4.62 | -1.84 | -1.84 | 5.14 | 7.26 | 0.2636 | 1.93 | 2.53 | 566,479.70 | -11.36 | -1.99 | -18.19 | -2.69 | 24.46 | 36.16 | -43.08 | -6.59 | 0.5483 | -2.10 | 0.4726 | -- | -16.54 | 5.42 | -242.62 | -- | -10.54 | -- |
| Jiangsu gdk Biotechnology Co Ltd | 116.56m | -126.51m | 2.44bn | 452.00 | -- | 2.05 | -- | 20.94 | -1.03 | -1.03 | 0.9461 | 9.67 | 0.0775 | 0.7322 | 1.14 | 257,878.40 | -8.42 | 1.65 | -9.84 | 2.14 | 60.80 | 73.17 | -108.54 | 7.56 | 1.83 | -- | 0.0465 | 53.80 | -39.96 | 3.77 | -31.71 | -- | 12.74 | -- |
| Hangzhou Tianmushan Phrmtcl ntrprs C Ltd | 251.56m | 33.15m | 2.45bn | 362.00 | 73.86 | 36.78 | -- | 9.74 | 0.2723 | 0.2723 | 2.07 | 0.5468 | 0.632 | 2.97 | 2.32 | 694,905.80 | 8.32 | -8.84 | 27.42 | -25.80 | 47.93 | 32.17 | 13.17 | -21.83 | 0.655 | 9.23 | 0.648 | -- | 78.44 | -6.06 | 139.83 | -21.36 | -26.32 | -- |
| Zhejiang East Asia Pharmaceutical Co Ltd | 831.56m | -218.24m | 2.47bn | 1.75k | -- | 1.36 | -- | 2.97 | -1.97 | -1.97 | 7.34 | 15.80 | 0.2409 | 0.8634 | 5.60 | 475,447.80 | -6.33 | 2.47 | -8.09 | 3.12 | 25.78 | 24.66 | -26.25 | 5.78 | 0.7513 | -411.46 | 0.3533 | 42.92 | -11.66 | 3.93 | -183.02 | -- | 29.64 | -- |
| Hainan Huluwa Pharmaceutical Grop Co Ltd | 902.48m | -369.56m | 2.70bn | 2.10k | -- | 3.92 | -- | 2.99 | -0.9236 | -0.9236 | 2.26 | 1.72 | 0.3055 | 1.74 | 1.60 | 429,141.60 | -12.36 | 0.2178 | -22.13 | 0.3739 | 31.53 | 54.80 | -40.47 | 0.3213 | 0.5566 | -6.97 | 0.6414 | 700.10 | -21.26 | 1.60 | -2,629.23 | -- | 21.75 | -- |
| Zhejiang Shapuaisi Pharmaceutical Co Ltd | 475.19m | -65.05m | 2.75bn | 1.33k | -- | 1.71 | -- | 5.79 | -0.1796 | -0.1796 | 1.27 | 4.31 | 0.2236 | 2.35 | 14.31 | 357,822.00 | -3.08 | -2.12 | -3.66 | -2.49 | 50.11 | 55.38 | -13.78 | -7.33 | 0.8289 | -0.9506 | 0.1587 | -- | -24.96 | -1.27 | -585.85 | -- | 44.50 | -- |
Data as of Feb 13 2026. Currency figures normalised to Jiangsu GDK Biotechnology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
1.02%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 79.67k | 0.19% |
| Lion Fund Management Co., Ltd.as of 30 Jun 2025 | 75.00k | 0.18% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 65.85k | 0.15% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 39.63k | 0.09% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 38.93k | 0.09% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 32.64k | 0.08% |
| Fortune & Royal Asset Management Co., Ltd.as of 30 Jun 2025 | 32.50k | 0.08% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 28.09k | 0.07% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2025 | 22.33k | 0.05% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 21.97k | 0.05% |
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
